Brian Irving Carr

23PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersHaematologyHaematological tumoursLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 25, 2026
Dynamic Changes in Serum AFP, Albumin and ALBI after Radioembolization in Patients with Unresectable Hepatocellular Carcinoma with High or Low Alpha-Fetoprotein Levels.

|May 04, 2026
HALP Score in Predicting Post-Liver Transplant Outcomes in Patients with Hepatocellular Carcinoma.

|Oct 22, 2025
Inflammation Markers and HCC Aggressiveness.

Brian Irving Carr, Rossella Donghia

|Sep 03, 2025
A Network Phenotyping Strategy approach in a Turkish HCC Dataset and Comparison of Patients Selected for Transplant and those who were not.

Petr Pancoska, Brian Irving Carr, Volkan Ince

|Jul 14, 2025
Transplant Versus Non-Transplant Hepatocellular Carcinoma Patient Characteristics And Survival.

Brian I Carr, Volkan Ince, Harika Gozukara Bag

|Apr 07, 2025
A New Approach to Analysis of Clinical Data and Prognostication for Patients with Hepatocellular Carcinoma, Based Upon a Network Phenotyping Strategy (NPS) Computational Method.

Brian Carr, Patricia Sotáková, Petr Pancoska

Pageof 4

Frequent Collaborators

9 joint publications

Sezai Yilmaz

6 joint publications

Volkan Ince

5 joint publications

Harika Gozukara Bag

4 joint publications

Sertac Usta